A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial

Arun Nanditha, Hazel Thomson, Priscilla Susairaj, Weerachai Srivanichakorn, Nick Oliver, Ian F Godsland, Azeem Majeed, Ara Darzi, Krishnamoorthy Satheesh, Mary Simon, Arun Raghavan, Ramachandran Vinitha, Chamukuttan Snehalatha, Kate Westgate, Soren Brage, Stephen J Sharp, Nicholas J Wareham, Desmond G Johnston, Ambady Ramachandran, Arun Nanditha, Hazel Thomson, Priscilla Susairaj, Weerachai Srivanichakorn, Nick Oliver, Ian F Godsland, Azeem Majeed, Ara Darzi, Krishnamoorthy Satheesh, Mary Simon, Arun Raghavan, Ramachandran Vinitha, Chamukuttan Snehalatha, Kate Westgate, Soren Brage, Stephen J Sharp, Nicholas J Wareham, Desmond G Johnston, Ambady Ramachandran

Abstract

Aims/hypothesis: This randomised controlled trial was performed in India and the UK in people with prediabetes to study whether mobile phone short message service (SMS) text messages can be used to motivate and educate people to follow lifestyle modifications, to prevent type 2 diabetes.

Methods: The study was performed in people with prediabetes (n = 2062; control: n = 1031; intervention: n = 1031) defined by HbA1c ≥42 and ≤47 mmol/mol (≥6.0% and ≤6.4%). Participants were recruited from public and private sector organisations in India (men and women aged 35-55 years) and by the National Health Service (NHS) Health Checks programme in the UK (aged 40-74 years without pre-existing diabetes, cardiovascular disease or kidney disease). Allocation to the study groups was performed using a computer-generated sequence (1:1) in India and by stratified randomisation in permuted blocks in the UK. Investigators in both countries remained blinded throughout the study period. All participants received advice on a healthy lifestyle at baseline. The intervention group in addition received supportive text messages using mobile phone SMS messages 2-3 times per week. Participants were assessed at baseline and at 6, 12 and 24 months. The primary outcome was conversion to type 2 diabetes and secondary outcomes included anthropometry, biochemistry, dietary and physical activity changes, blood pressure and quality of life.

Results: At the 2 year follow-up (n = 2062; control: n = 1031; intervention: n = 1031), in the intention-to-treat population the HR for development of type 2 diabetes calculated using a discrete-time proportional hazards model was 0.89 (95% CI 0.74, 1.07; p = 0.22). There were no significant differences in the secondary outcomes.

Conclusions/interpretation: This trial in two countries with varied ethnic and cultural backgrounds showed no significant reduction in the progression to diabetes in 2 years by lifestyle modification using SMS messaging.

Trial registration: The primary study was registered on www.ClinicalTrials.gov (India, NCT01570946; UK, NCT01795833).

Funding: The study was funded jointly by the Indian Council for Medical Research and the UK Medical Research Council.

Keywords: Behavioural change; Diabetes prevention; Glycosylated haemoglobin A1c; Lifestyle modification; Mobile technology; Prediabetes; Screening; Short message service.

Figures

Fig. 1
Fig. 1
CONSORT diagram of trial profile. FPG, fasting plasma glucose
Fig. 2
Fig. 2
Cumulative percentage of individuals with type 2 diabetes at each follow-up visit
Fig. 3
Fig. 3
Effect of intervention on primary outcome (the development of type 2 diabetes) overall (p = 0.22) and by pre-specified subgroups (intervention × country interaction: p = 0.33; intervention × sex interaction: p = 0.12)
Fig. 4
Fig. 4
Overall effect of intervention on secondary outcomes (n = 2062). Intervention effects represent differences between intervention and control groups, estimated from a linear regression model with random intercepts at the individual level, using measures of the outcome at all follow-up times, and including baseline value of the outcome, country, randomised group and time (months of follow-up). Intervention effects are presented in units of baseline SD of each outcome. Triacylglycerol results are presented using log-transformed values. MVPA, moderate-to-vigorous physical activity

References

    1. International Diabetes Federation (2017) IDF Diabetes Atlas, 8th edition. IDF, Brussels Available from . Last accessed 20 Mar 2019
    1. Ramachandran A, Snehalatha C, Shetty SA, Nanditha A. Global health perspectives in prediabetes and diabetes prevention. In: Bergman M, editor. Primary prevention trials in type 2 diabetes. Singapore: World Scientific Publishing; 2014. pp. 49–74.
    1. Galaviz KI, Weber MB, Straus A, Haw JS, Narayan KMV, Ali MK. Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose. Diabetes Care. 2018;41(7):1526–1534. doi: 10.2337/dc17-2222.
    1. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Primary prevention of type 2 diabetes in South Asians—challenges and the way forward. Diabet Med. 2013;30(1):26–34. doi: 10.1111/j.1464-5491.2012.03753.x.
    1. Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009;36(2):165–173. doi: 10.1016/j.amepre.2008.09.040.
    1. Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32:56–69. doi: 10.1093/epirev/mxq004.
    1. WHO (2011) mHealth: new horizons for health through mobile technologies. Second global survey on eHealth. Available from . Accessed 20 Apr 2016
    1. Shetty AS, Chamukuttan S, Nanditha A, Raj RK, Ramachandran A. Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS)—a pilot study. J Assoc Physicians India. 2011;59:711–714.
    1. Ramachandran A, Snehalatha C, Ram J, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomized controlled trial. Lancet Diabetes Endocrinol. 2013;1(3):191–198. doi: 10.1016/S2213-8587(13)70067-6.
    1. Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314(12):1255–1263. doi: 10.1001/jama.2015.10945.
    1. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176(3):340–349. doi: 10.1001/jamainternmed.2015.7667.
    1. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93:299–309
    1. Thomson H, Oliver N, Godsland IF, et al. Protocol for a clinical trial of text messaging in addition to standard care versus standard care alone in prevention of type 2 diabetes through lifestyle modification in India and the UK. BMC Endocr Disord. 2018;18(1):63. doi: 10.1186/s12902-018-0293-8.
    1. National Institute for Health and Clinical Excellence (2012) Type 2 diabetes: prevention in people at high risk (PH38). Available from . Last Accessed 14 May 2019
    1. John WG, Hillson R, Alberti G. Use of haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus. The implementation of World Health Organization (WHO) guidance 2011. Pract Diab. 2011;29:12–12a. doi: 10.1002/pdi.1648.
    1. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48. doi: 10.4278/0890-1171-12.1.38.
    1. Mulligan AA, Luben RN, Bhaniani A, et al. A new tool for converting food frequency questionnaire data into nutrient and food group values: FETA research methods and availability. BMJ Open. 2014;4(3):e004503. doi: 10.1136/bmjopen-2013-004503.
    1. Madden JP, Goodman SJ, Guthrie HA. Validity of the 24-hr. recall. Analysis of data obtained from elderly subjects. J Am Diet Assoc. 1976;68(2):143–147.
    1. Besson H, Brage S, Jakes RW, Ekelund U, Wareham NJ. Estimating physical activity energy expenditure, sedentary time, and physical activity intensity by self-report in adults. Am J Clin Nutr. 2010;91(1):106–114. doi: 10.3945/ajcn.2009.28432.
    1. White T, Westgate K, Hollidge S. Estimating energy expenditure from wrist and thigh accelerometry in free-living adults: a doubly labelled water study. Int J Obes. 2019;43(11):2333–2342. doi: 10.1038/s41366-019-0352-x.
    1. Corder K, Brage S, Ramachandran A, Snehalatha C, Wareham N, Ekelund U. Comparison of two ActiGraph models for assessing free-living physical activity in Indian adolescents. J Sports Sci. 2007;25(14):1607–1611. doi: 10.1080/02640410701283841.
    1. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33(5):337–343. doi: 10.3109/07853890109002087.
    1. Prentice RL, Gloeckler LA. Regression analysis of grouped survival data with application to breast cancer data. Biometrics. 1978;34(1):57–67. doi: 10.2307/2529588.
    1. Müller AM, Alley S, Schoeppe S, Vandelanotte C. The effectiveness of e-& mHealth interventions to promote physical activity and healthy diets in developing countries: a systematic review. Int J Behav Nutr Phys Act. 2016;13(1):109–114. doi: 10.1186/s12966-016-0434-2.
    1. Grock S, Ku JH, Kim J, Moin T. A review of technology-assisted interventions for diabetes prevention. Curr Diab Rep. 2017;17(11):107–112. doi: 10.1007/s11892-017-0948-2.
    1. Scott-Sheldon LA, Lantini R, Jennings EG, et al. Text messaging-based interventions for smoking cessation: a systematic review and meta-analysis. JMIR Mhealth Uhealth. 2016;4(2):e49. doi: 10.2196/mhealth.5436.
    1. Glechner A, Harreiter J, Gartlehner G et al (2015) Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia 58(2):242–254. 10.1007/s00125-014-3439-x
    1. Bartoli E, Fra GP, Carnevale Schianca GP. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med. 2011;22(1):8–12. doi: 10.1016/j.ejim.2010.07.008.
    1. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR) J Intern Med. 2010;268(5):471–482. doi: 10.1111/j.1365-2796.2010.02265.x.
    1. Davies MJ, Gray LJ, Ahrabian D et al (2017) A community-based primary prevention programme for type 2 diabetes mellitus integrating identification and lifestyle intervention for prevention: a cluster randomised controlled trial. Programme Grants Appl Res 5(2). 10.1016/j.ypmed.2015.12.012
    1. Knowler WC, Barrett-Connor E, Fowler SE, et al. The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi: 10.1056/NEJMoa012512.
    1. Fischer HH, Fischer IP, Pereira RI, et al. Text message support for weight loss in patients with prediabetes: a randomized clinical trial. Diabetes Care. 2016;39(8):1364–1370. doi: 10.2337/dc15-2137.
    1. Lombard C, Harrison C, Kozica S, Zoungas S, Ranasinha S, Teede H. Preventing weight gain in women in rural communities: a cluster randomized controlled trial. PLoS Med. 2016;13(1):e1001941. doi: 10.1371/journal.pmed.1001941.
    1. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–1845. doi: 10.1016/S0140-6736(10)61997-6.
    1. Free C, Knight R, Robertson S et al (2011) Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet 378(9785):49–55. 10.1016/S0140-6736(11)60701-0
    1. Fottrell E, Ahmed N, Morrison J, et al. Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(3):200–212. doi: 10.1016/S2213-8587(19)30001-4.
    1. Joiner KL, Nam S, Whittemore R. Lifestyle interventions based on the diabetes prevention program delivered via eHealth: a systematic review and meta-analysis. Prev Med. 2017;100:194–207. doi: 10.1016/j.ypmed.2017.04.033.

Source: PubMed

3
Tilaa